Endometrial Receptivity Analysis (ERA)
ERA is a breakthrough diagnostic test that helps determine the best time to transfer an embryo by evaluating your endometrium's receptivity.
What is the ERA Test?
The ERA test analyzes a biopsy sample of your endometrium (uterine lining) to identify when it is most receptive to embryo implantation. This timing varies from woman to woman and is critical to IVF success.
By adjusting the timing of embryo transfer based on ERA results, patients with repeated implantation failure can increase their chances of a successful pregnancy.
Why ERA Matters
- Improves implantation success in IVF
- Reduces trial-and-error in embryo transfer timing
- Highly recommended after repeated failed IVF cycles
- Personalized embryo transfer planning
ERA Process Timeline
Step 1: Cycle Monitoring
Hormone levels and endometrial thickness are monitored to prepare for biopsy.
Step 2: Biopsy Collection
A small sample of endometrial tissue is collected during the luteal phase (5–7 days after ovulation).
Step 3: Gene Expression Analysis
The sample is analyzed for the expression of 238 genes to determine the receptivity window.
Step 4: Personalized Timing
Embryo transfer is scheduled based on your unique window of implantation.
Who Should Consider ERA?
- Women with 2 or more failed IVF transfers
- Normal uterus and embryo quality, but no pregnancy
- History of implantation failure despite PGT-A embryos
- Advanced maternal age with thin endometrium
ERA Testing at DAARA Hospital
DAARA Hospital offers seamless ERA integration into IVF cycles with in-house diagnostics, experienced fertility experts, and personalized care planning. We use evidence-based methods to boost success rates for patients struggling with implantation.
FAQs
Is ERA painful?
The biopsy may cause mild discomfort similar to a menstrual cramp but is quick and safe.
Does ERA guarantee pregnancy?
ERA doesn't guarantee success, but significantly improves the chance by optimizing timing.